Progressive Care Inc. Announces Best January in Company History
MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for January 2019.
In January, the company reported a total of $1.9 million in net revenue, a 5.5% increase from the same month last year, and a 31% increase in prescriptions filled during the same month last year, totaling nearly 31,000 prescriptions filled. This marks the strongest January in Company history.
The Company is continuing to move forward on the acquisition process, working through the final agreements and documents necessary to facilitate the change of ownership transition. The Company has reached agreement on all principal terms with the sellers and is awaiting last reviews and approvals on paperwork to fund escrow.
“We started 2019 on a great note. Progressive Care exceeded December 2018 prescriptions filled and is moving forward on major initiatives,” said S. Parikh Mars, CEO of Progressive Care. “We are excited to fund escrow on the acquisition soon and start the transitional regulatory process. We are confident that our growth strategy will yield results in 2019, allowing us to take the next big steps in our development.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking StatementsStatements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:Armen Karapetyan, Progressive CareSenior Advisor Business DevelopmentArmen@progressivecareus.comwww.progressivecareus.comwww.pharmcopharmacy.com
Public Relations Contact:Kathleen Gonzales, CMW MediaKathleen@cmwmedia.comwww.cmwmedia.com
Web and Application Development Contact:Marcello Jaspan, Mass Ventures CorpMarcello@massventurescorp.comwww.massventurescorp.com